Yin Haiqing, Kang Han Chang, Huh Kang Moo, Bae You Han
Department of Pharmaceutics and Pharmaceutical Chemistry, The University of Utah, 30 S 2000 E, Room 2972, Salt Lake City, UT 84112, USA.
Department of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do 420-743, Republic of Korea.
Colloids Surf B Biointerfaces. 2014 Apr 1;116:128-37. doi: 10.1016/j.colsurfb.2013.12.041. Epub 2013 Dec 30.
In our previous study, a histidine-based AB2 miktoarm polymer, methoxy poly(ethylene glycol)-b-poly(l-histidine)2 (mPEG-b-(PolyHis)2), was designed to construct pH-sensitive polymersomes that transform in acidic pH; the polymer self-assembles into a structure that mimics phospholipids. In this study, the polymersomes further imitated liposomes due to the incorporation of cholesterol (CL). The hydrodynamic radii of the polymersomes increased with increasing CLwt% (e.g., 70 nm for 0 wt% vs. 91 nm for 1 wt%), resulting in an increased capacity for encapsulating hydrophilic drugs (e.g., 0.92 μL/mg for 0 wt% vs. 1.42 μL/mg for 1 wt%). The CL incorporation enhanced the colloidal stability of the polymersomes in the presence of serum protein and retarded their payload release. However, CL-incorporating polymersomes still demonstrated accelerated release of a hydrophilic dye (e.g., 5(6)-carboxyfluorescein (CF)) below pH 6.8 without losing their desirable pH sensitivity. CF-loaded CL-incorporating polymersomes showed better cellular internalization than the hydrophilic CF, whereas doxorubicin (DOX)-loaded CL-incorporating polymersomes presented similar or somewhat lower anti-tumor effects than free hydrophobic DOX. The findings suggest that CL-incorporating mPEG-b-(PolyHis)2-based polymersomes may have potential for intracellular drug delivery of chemical drugs due to their improved colloidal stability, lower drug loss during circulation, acidic pH-induced drug release, and endosomal disruption.
在我们之前的研究中,设计了一种基于组氨酸的AB2型 miktoarm 聚合物,即甲氧基聚(乙二醇)-b-聚(L-组氨酸)2(mPEG-b-(聚组氨酸)2),用于构建在酸性pH值下转变的pH敏感聚合物囊泡;该聚合物自组装成一种模仿磷脂的结构。在本研究中,由于加入了胆固醇(CL),聚合物囊泡进一步模仿了脂质体。聚合物囊泡的流体动力学半径随着CL重量百分比的增加而增大(例如,0重量%时为70nm,1重量%时为91nm),导致包封亲水性药物的能力增强(例如,0重量%时为0.92μL/mg,1重量%时为1.42μL/mg)。CL的加入增强了聚合物囊泡在血清蛋白存在下的胶体稳定性,并延缓了其载药量的释放。然而,含CL的聚合物囊泡在pH 6.8以下仍表现出亲水性染料(如5(6)-羧基荧光素(CF))的加速释放,同时不失其理想的pH敏感性。负载CF的含CL聚合物囊泡比亲水性CF表现出更好的细胞内化,而负载阿霉素(DOX)的含CL聚合物囊泡与游离疏水性DOX相比,表现出相似或略低的抗肿瘤效果。这些发现表明,含CL的基于mPEG-b-(聚组氨酸)2的聚合物囊泡由于其改善的胶体稳定性、循环过程中较低的药物损失、酸性pH诱导的药物释放和内体破坏,可能在化学药物的细胞内药物递送方面具有潜力。